002102SZSE

Announcement on Accruing Asset Impairment Provisions

✨ AI Summary

Hubei Nute Technology Co., Ltd. announces its decision to accrue asset impairment provisions totaling RMB 230,551,136.32 for 2025, primarily due to goodwill impairment. This provision is expected to reduce net profit attributable to shareholders by the same amount and will not significantly impact normal operations. The decision has been reviewed and approved by the Audit Committee and the Board of Directors.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_documentSign In to Upgrade

Securities Code: 002102 Securities Abbreviation: Nute Technology Announcement No.: 2026-021

Hubei Nute Technology Co., Ltd. Announcement on Accruing Asset Impairment Provisions

The Company and all members of its Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false representations, misleading statements, or material omissions.

In accordance with the "Equity Listing Rules of the Shenzhen Stock Exchange," "Shenzhen Stock Exchange Listed Company Self-Regulation Guidelines No. 1 - Normative Operation of Main Board Listed Companies," and other relevant laws, regulations, normative documents, and the "Articles of Association," based on the principle of prudence, Hubei Nute Technology Co., Ltd. (hereinafter referred to as the "Company") will accrue asset impairment provisions within the scope of the consolidated financial statements for the year 2025. The specific details are as follows:

I. Overview of the Accrual of Asset Impairment Provisions This Time

  1. Reason for Accruing Asset Impairment Provisions This Time

To objectively, truthfully, and accurately reflect the Company's financial position, asset value, and operating conditions as of December 31, 2025, based on the principle of prudence and in accordance with the "Enterprise Accounting Standards" and the Company's relevant accounting treatment regulations, the Company (including its subsidiaries within the consolidated statements, hereinafter referred to as the same) has conducted a comprehensive review of various assets as of December 31, 2025, performed impairment tests on relevant assets, and accrued corresponding asset impairment provisions as required.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Notes & Comments

Sign in to leave a comment or private note.

Loading…